This link will take you to a Web site maintained by a third party who is solely responsible for its contents. ARIAD Pharmaceuticals, Inc. and Merck & Co., Inc. provide this link as a service to Web site visitors. ARIAD Pharmaceuticals, Inc. and Merck & Co., Inc. are not responsible for the privacy policy of any third party Web sites. We encourage you to read the privacy policy of every Web site you visit. Click CANCEL to return or OK to continue.
OKCancel
The information requested is intended for US healthcare professionals only. I am a healthcare professionalI am not a healthcare professional
The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "VIEW PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

View PDF Cancel

Don't show me this message again.
 

Forgot Password?

Enter your e-mail address and you will receive your login information via e-mail.



The SUCCEED trial Web site is intended for US residents only. It is intended for Investigators, Healthcare Professionals, and Patients and Caregivers. The use of deforolimus (AP23573, MK-8669) is limited to investigational trials. There is no guarantee that its use will be approved by the US Food and Drug Administration.

This site is brought to you by ARIAD Pharmaceuticals, Inc. and Merck & Co., Inc.
© 2008 ARIAD Pharmaceuticals, Inc.
Copyright © 2008 Merck & Co., Inc. All rights reserved.

ARIADMERCK